[Chronic renal failure and hypertension in community cardiology practice]

J Chanard1

  • 1Service de Néphrologie, Centre Hospitalier et Universitaire, Reims. jchanard@chu-reims.fr

Presse Medicale (Paris, France : 1983)
|October 18, 2001
PubMed

Insights

Many hypertensive patients have undiagnosed renal insufficiency. Using the Cockcroft and Gault formula for creatinine clearance is crucial for accurate assessment of kidney function in these individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Context:

  • Vascular nephropathies are increasing in Western countries, linked to aging.
  • Renal failure in hypertensive patients is often diagnosed late, leading to poor outcomes.
  • Serum creatinine alone is an unreliable measure of renal function.

Purpose:

  • To assess the prevalence of renal insufficiency in hypertensive patients.
  • To compare renal function estimates using serum creatinine versus creatinine clearance.
  • To highlight the underdiagnosis of renal failure in cardiology practice.

Summary:

  • An epidemiological survey of 2,100 hypertensive patients in France revealed significant renal insufficiency.
  • 32% had creatinine clearance <60 ml/min, and 61% <80 ml/min, indicating underdiagnosis.
  • The Cockcroft and Gault formula is recommended for accurate assessment over serum creatinine alone.

Impact:

  • This study underscores the need for routine use of creatinine clearance in hypertensive patients.
  • Implementing the Cockcroft and Gault formula can improve early detection and management of renal disease.
  • Accurate renal function assessment is vital for preventing complications and improving patient outcomes.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...